Učitavanje...
Improving the Utility of Polygenic Risk Scores as a Biomarker for Alzheimer’s Disease
The treatment of complex and multifactorial diseases constitutes a big challenge in day-to-day clinical practice. As many parameters influence clinical phenotypes, accurate diagnosis and prompt therapeutic management is often difficult. Significant research and investment focuses on state-of-the-art...
Spremljeno u:
| Izdano u: | Cells |
|---|---|
| Glavni autori: | , , , , , , , , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
MDPI
2021
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8305482/ https://ncbi.nlm.nih.gov/pubmed/34209762 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cells10071627 |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|